Lisa Wilson | Investor Relations |
Scott Tarriff | President and Chief Executive Officer |
Mike Greenberg | Vice President-Medical Affairs |
Brian Cahill | Chief Financial Officer |
Lachlan Hanbury-Brown | William Blair |
David Amsellem | Piper Sandler |
Good morning, everyone. My name is Katie and I will be your conference operator. At this time, I would like to welcome everyone to the Eagle Pharmaceuticals Second Quarter 2022 Financial Results. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer period.